Spindletop Capital

Spindletop Capital, founded in 2011 and based in Austin, Texas, is a private equity and venture capital firm that focuses on investments in the healthcare sector and related technologies. The firm seeks to identify opportunities within various areas, including healthcare services, distribution, biopharma, specialty pharmaceuticals, healthcare information technology, medical diagnostics, and medical devices. Spindletop Capital manages multiple investment funds, including the Spindletop Fargo Partners and Spindletop Pharmaceutical Partners Fund, both of which are dedicated to advancing healthcare innovation and improving patient outcomes. As a Registered Investment Adviser, Spindletop Capital is committed to fostering growth in its portfolio companies while contributing to advancements in healthcare.

Stephen Hipp

Managing Director

Steven Whitlock

Managing Director

5 past transactions

Interventional Pain Management

Private Equity Round in 2020
Address: 110 Stone Oak Pkwy, San Antonio TX 78258 Main Phone: 210-268-0129 Business Email: paindoc@sapaindoc.com Business Website: http://www.sapaindoc.com Interventional Pain Management under the guidance of Dr. Urfan Dar offers a unique approach to avoid chronic pain to maintain quality of life. Helping people alleviate back and neck pain in San Antonio and New Braunfels we are the best pain management doctors and specialists in the area. Call us today for a consultation. Services: Pain Management, Minimally Invasive Laser Spine Surgery Hours: Mon to Fri 8:00 AM to 5:00 PM , Sat & Sun : Closed Payment Methods: amex, debit, mc, discover, visa

Castle Biosciences

Venture Round in 2019
Castle Biosciences is a biotech company that develops and validates diagnostic tests and technologies for the treatment of cancer. The company also focused on providing physicians and patients with personalized, clinically actionable genomic information to make more accurate treatment plan decisions. The DecisionDx family of molecular diagnostic tests have the ability to meaningfully impact how cancers are diagnosed and managed and the DecisionDx-Melanoma predicts risk of recurrence or metastasis for patients with invasive cutaneous melanoma, a deadly skin cancer, including the risk of sentinel lymph node positivity. Castle Biosciences was founded in 2008 and is headquartered in Friendswood, Texas, United States.

HNI Healthcare

Series E in 2018
HNI Healthcare (formerly Hospitalists Now) is a technology-enabled physician practice management company focused on the delivery of full-service facility-based physician programs to improve the quality of patient care. The Company’s physicians, processes and technologies enable healthcare facilities to improve key quality and performance metrics through a more clinically integrated care model.

Qspex Technologies

Debt Financing in 2015
QSpex Technologies, Inc. has developed a unique and patented method to produce high quality premium lenses right in your office. It’s simple, cost effective and, above all, the lenses and treatment options provide the high quality you demand for your patients. All lens treatments are pre-applied to the inside surface of each mold and transfer to become part of the lens during the polymerization (curing) process.

Qspex Technologies

Series D in 2012
QSpex Technologies, Inc. has developed a unique and patented method to produce high quality premium lenses right in your office. It’s simple, cost effective and, above all, the lenses and treatment options provide the high quality you demand for your patients. All lens treatments are pre-applied to the inside surface of each mold and transfer to become part of the lens during the polymerization (curing) process.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.